Financhill
Back

Perspective Therapeutics Stock Predictions

Buy
52

CATX
Perspective Therapeutics

Last Price:
1.60
Seasonality Move:
2.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Perspective Therapeutics Stock Forecast

  • Is Perspective Therapeutics Stock Undervalued?
    The current Perspective Therapeutics [CATX] share price is $1.60. The Score for CATX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics Stock Go Up Next Year?

Data Unavailable

Perspective Therapeutics Stock Rating

Data Unavailable

Perspective Therapeutics Stock Price History

Is CATX stock going to rise?

  • The current trend is moderately bearish and CATX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
1.91
52-Week Low:
0.21

Prediction Charts

Market Cap:
996.21M
Price in USD:
1.60
Volume:
5.53M
Beta:
1.38

Technical Analysis

SMA50:
1.47
SMA100:
1.10
SMA200:
0.71
52-Wk Change:
252.66%

Stock Predictions

  • Is Perspective Therapeutics stock public?
    Yes, Perspective Therapeutics is a publicly traded company.
  • What is the Perspective Therapeutics stock quote today?
    The Perspective Therapeutics stock price is 1.60 USD today.
  • How to buy Perspective Therapeutics stock online?
    You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 1.67 1.68 1.71 1.60
May-1 1.68 1.70 1.75 1.65
May-2 1.76 1.73 1.87 1.71
May-3 1.75 1.81 1.87 1.72
May-6 1.84 1.83 1.85 1.79
May-7 1.84 1.84 1.90 1.81
May-8 1.83 1.76 1.85 1.70
May-9 1.80 1.80 1.83 1.73
May-10 1.80 1.75 1.81 1.66
May-13 1.74 1.74 1.78 1.65
May-14 1.77 1.76 1.78 1.71
May-15 1.81 1.57 1.91 1.32
May-16 1.57 1.53 1.60 1.44
May-17 1.53 1.60 1.68 1.52

Perspective Therapeutics Earnings

Data Unavailable

Perspective Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.